B
Power Law company profile
BGI
Biotech & Life Sciences · Shenzhen, China · Founded 1999 · IPO 2017 Unicorn
Valuation
$1.94B
Market cap · Apr/2026
Revenue
$509M
Latest reported FY
Global footprint
Where BGI has talent and traffic
AI talent share
0.2%
of workforce is AI talent
(5 of 3,039 staff)
(5 of 3,039 staff)
Core AI50.16%
Other AI00%
Non-AI workforce3,03499.84%
Web traffic by country
90K
monthly visits
across markets
across markets
🇨🇳 China36.8%
🇺🇸 United States7%
🇭🇰 Hong Kong4.7%
🇩🇪 Germany4.4%
🇦🇺 Australia4.2%
Patent intelligence
$627M patent portfolio · 2,771 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$627M
32.3% of market cap · 4.4× smaller than top peer Illumina ($2.7B)
2,771 active patent families
Where BGI innovates
BioinformaticsMolecular biologyComputational biologyNucleic acidLibrary
Below peer median on Strategic, Market
Quality vs same-sector peers
BGI on the five Patsnap quality dimensions
BGI in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where BGI concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across BGI and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee BGI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.